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Why breast cancer? Why antisense lncRNAs?
● Most frequent cancer type in women
( ∼35% of female cancers)
● First cause of cancer death in women
(∼35% of cancer deaths)
● ⅛ women will have breast cancer during
their lifetime
● Breast cancer involves several genes
● Genetic alteration mechanisms not always well known
● Some of these mechanisms involve antisense lncRNAs
● Long non-coding RNAs (lncRNAs) = non protein-coding transcripts 
longer than 200 nt
● Antisense lncRNA or natural antisense transcript (NAT) = lncRNA
○ Sharing the same genomic location as a protein-coding gene
○ Transcribed in the opposite direction
○ Overlapping > 1 exon
● NATs
○ Regulate protein-coding gene expression
○ Overlap more than 50% of sense RNA transcripts
○ Have a lower expression than protein-coding genes


















○ RNA-Seq fold-changes vs. CGH (all genes)
○ RNA-Seq fold-changes vs. microarray 
fold-changes (external study)
○ RNA-Seq vs. RT-qPCR 
(subset of genes)




Overall expression levels of coding gene transcripts inside 
genomic amplification or deletion newly acquired in the 
tumor were respectively increased and decreased.
RNA-Seq PCA:
Appropriate separation between the sample classes.
RNA-Seq vs microarray:
Comparison with GEO Dataset GSE65216
● Average Spearman correlation: 0.613 (p-val < 0.001)
● 76.6% of genes modulated in the same direction
RNA-Seq vs RT-qPCR:
Small set of genes (protein coding and antisenses)
Differential expression analysis (DESeq2)





























RNA-Seq pipeline Validation of RNA-Seq data Antisenses selection methods Filtering of significant / extreme antisenses
Test for enrichment in 
survival-associated genes
Conclusion
This is the first breast cancer-based, transcriptome-wide, strand-specific RNA-Seq study 
performed with paired tumor and adjacent tissue samples. Our results show that opposite 
strand transcription regulation might play a key role in the breast cancer disease, involving 
several different protein-coding genes and antisenses. Further functional molecular studies 
will be needed to explore the mechanisms and roles of specific antisenses.
Global over-expression of antisenses in 
breast cancer tumors
Highlighting of pairs of antisense/protein 
coding genes linked to survival




in breast cancer 
tumors
Modifications of NAT/PCT correlations between healthy samples and tumors
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